Webinar: BioSimilars Labelling
The European Biopharmaceutical Enterprises (EBE) and the European Association for Bioindustries (EuropaBio) organised a multi-stakeholder Biosimilar Labelling workshop in Brussels on 2 February 2016.
The main aim of the workshop was to gain an understanding of how stakeholders use or consult medicinal product information and to investigate their preferences regarding the content of biosimilar labels. The focus was on perspectives of end-users of product labels, namely patients, physicians and pharmacists. During the workshop, reference was made to ‘the label’ without further specification. From the context of the discussion, this may mean the label on the outer packaging of the product, the Summary of product Characteristics (SmPC), the Patient Leaflet (PL) or all elements of the product literature.
In this webinar we will continue to discuss biosimilars labelling and comment on the report with the following speakers:
- Keith Watson PhdDirector Global Regulatory Affairs Biologics Strategic DevelopmentAbbvie
- Sanna LonnforsMedical WriterEuropean Federation of Crohn's and Ulcerative Colitis Associations